Cargando…

Can DKI-MRI predict recurrence and invasion of peritumoral zone of hepatocellular carcinoma after transcatheter arterial chemoembolization?

BACKGROUND: Hepatocellular carcinoma (HCC) is a major cause of cancer-related mortality worldwide. Transcatheter arterial chemoembolization (TACE) has been performed as a palliative treatment for patients with HCC. However, HCC is easy to recur after TACE. Magnetic resonance imaging (MRI) has clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Xin, Shi, Hao, Dou, Wei-Qiang, Zhao, Xin-Yao, Zheng, Ying-Xin, Ge, Ya-Ping, Cheng, Hai-Chao, Geng, Dao-Ying, Wang, Jun-Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640335/ https://www.ncbi.nlm.nih.gov/pubmed/36386402 http://dx.doi.org/10.4240/wjgs.v14.i10.1150

Ejemplares similares

Intratumoral and peritumoral radiomics based on contrast-enhanced MRI for preoperatively predicting treatment response of transarterial chemoembolization in hepatocellular carcinoma
por: Zhao, Ying, et al.
Publicado: (2023)

Efficacy and safety analysis of transarterial chemoembolization and transarterial radioembolization in advanced hepatocellular carcinoma descending hepatectomy
por: Feng, Rui, et al.
Publicado: (2023)

Drug-eluting beads transarterial chemoembolization sequentially combined with radiofrequency ablation in the treatment of untreated and recurrent hepatocellular carcinoma
por: Zhang, Yan, et al.
Publicado: (2020)

Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization
por: Kuang, Donglin, et al.
Publicado: (2023)

Transhepatectomy combined with arterial chemoembolization and transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a clinical prognostic analysis
por: Liu, Xin, et al.
Publicado: (2023)

Diffusion Kurtosis Imaging for Assessing the Therapeutic Response of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma
por: Yuan, Zhen-Guo, et al.
Publicado: (2020)

Comparison of the Efficacy of Two Microsphere Embolic Agents for Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients
por: Lee, Shao-Hua, et al.
Publicado: (2020)

Initial Experience of Drug-Eluting Bead-Transcatheter Arterial Chemoembolization After Lipiodol-Based Transcatheter Arterial Chemoembolization Failure for Patients with Advanced Hepatocellular Carcinoma
por: Liu, Kai-Cai, et al.
Publicado: (2021)

Simultaneous transcatheter arterial chemoembolization and portal vein embolization for patients with large hepatocellular carcinoma before major hepatectomy
por: Zhang, Cheng-Wu, et al.
Publicado: (2020)

Resection versus Resection with Preoperative Transcatheter Arterial Chemoembolization for Resectable Hepatocellular Carcinoma Recurrence
por: Tao, Qiang, et al.
Publicado: (2018)

MRI Features for Predicting Microvascular Invasion and Postoperative Recurrence in Hepatocellular Carcinoma Without Peritumoral Hypointensity
por: Chen, Zhiyuan, et al.
Publicado: (2023)

Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
por: Liu, Yi-Sheng, et al.
Publicado: (2018)

Transcatheter Arterial Chemoembolization Plus (131)I-Labelled Metuximab versus Transcatheter Arterial Chemoembolization Alone in Intermediate/Advanced Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Zhu, Ze-xin, et al.
Publicado: (2016)

Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review
por: Shao, Zhiying, et al.
Publicado: (2021)

Peritumoral portal enhancement during transarterial chemoembolization: a potential prognostic factor for patients with hepatocellular carcinoma
por: Nyman, Sofi Sennefelt, et al.
Publicado: (2021)

Pulmonary complications of transcatheter arterial chemoembolization for hepatocellular carcinoma
por: Nhu, Quan M, et al.
Publicado: (2016)

Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma
por: Hatanaka, Takeshi, et al.
Publicado: (2018)

Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma
por: Yang, De-jun, et al.
Publicado: (2016)

Preliminary research of the classification of the brain acute stroke lesions by the Diffusion Kurtosis Imaging (DKI) and Diffusion Weighted Imaging (DWI) parameters
por: Liu, Xin, et al.
Publicado: (2023)

Evaluation of contrast-induced acute kidney injury using IVIM and DKI MRI in a rat model of diabetic nephropathy
por: Dai, Hongyan, et al.
Publicado: (2022)

Efficacy of Stereotactic Body Radiotherapy for Recurrent or Residual Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization
por: Yao, Erhua, et al.
Publicado: (2018)

Imaging response predictors following drug eluting beads chemoembolization in the neoadjuvant liver transplant treatment of hepatocellular carcinoma
por: Galastri, Francisco Leonardo, et al.
Publicado: (2020)

Application of DKI and IVIM imaging in evaluating histologic grades and clinical stages of clear cell renal cell carcinoma
por: Cheng, QiChao, et al.
Publicado: (2023)

Transcatheter arterial infusion chemotherapy with cisplatin in combination with transcatheter arterial chemoembolization decreases intrahepatic distant recurrence of unresectable hepatocellular carcinoma
por: Kawabe, Naoto, et al.
Publicado: (2021)

Drug-eluting Bead-Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma Refractory to Conventional Lipiodol-based Transcatheter Arterial Chemoembolization
por: Kobayashi, Saito, et al.
Publicado: (2020)

Comparison of Transcatheter Arterial Chemoembolization-Radiofrequency Ablation and Transcatheter Arterial Chemoembolization Alone for Advanced Hepatocellular Carcinoma with Macrovascular Invasion Using Propensity Score Analysis: A Retrospective Cohort Study
por: Liu, Yao, et al.
Publicado: (2020)

Transcatheter Arterial Chemoembolization Based on Hepatic Hemodynamics for Hepatocellular Carcinoma
por: Murata, Satoru, et al.
Publicado: (2013)

Transcatheter Arterial Chemoembolization Therapy for Patients With Unresectable Hepatocellular Carcinoma
por: Firouznia, Kavous, et al.
Publicado: (2014)

Hepatogastric Fistula following Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma
por: Grover, Inderpreet, et al.
Publicado: (2014)

The radiological prognostic factors of transcatheter arterial chemoembolization to hepatocellular carcinoma
por: Lee, Shou-Wu, et al.
Publicado: (2022)

Multifunctional nanoplatforms application in the transcatheter chemoembolization against hepatocellular carcinoma
por: Yuan, Gang, et al.
Publicado: (2023)

Lipiodol Pneumonitis Following Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
por: Kim, Sungkeun, et al.
Publicado: (2020)

Tumor Response to Transcatheter Arterial Chemoembolization in Recurrent Hepatocellular Carcinoma after Living Donor Liver Transplantation
por: Ko, Heung-Kyu, et al.
Publicado: (2007)

Transcatheter arterial chemoembolization plus sorafenib versus transcatheter arterial chemoembolization alone to treat advanced hepatocellular carcinoma: a meta-analysis
por: Cai, Rong, et al.
Publicado: (2017)

Spinal cord ischemia after transcatheter artery chemoembolization for hepatocellular carcinoma: A case-report
por: Hieu, Le Trung, et al.
Publicado: (2023)

Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma
por: Yin, Xin, et al.
Publicado: (2014)

Transcatheter arterial chemoembolization monotherapy vs combined transcatheter arterial chemoembolization–percutaneous microwave coagulation therapy for massive hepatocellular carcinoma (≥10 cm)
por: Wei, Yanyan, et al.
Publicado: (2018)

Quality of Life after Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Compared with Transcatheter Arterial Chemoembolization alone
por: Hassanin, Taha M, et al.
Publicado: (2021)

Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided radiofrequency ablation in the treatment of solitary large hepatocellular carcinoma
por: Yuan, Hongjun, et al.
Publicado: (2018)

Effect of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation on Liver Function and Immune Function in Patients with Hepatocellular Carcinoma
por: Zhou, Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7ekdj2rrt0o6b1kfb2h0m9ik3v